Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-25-002172
Filing Date
2025-03-24
Accepted
2025-03-24 17:10:37
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4593
  Complete submission text file 0001950047-25-002172.txt   6084
Mailing Address WALLSTRASSE 16 BERLIN 2M 10179
Business Address WALLSTRASSE 16 BERLIN 2M 10179 49 89 2153 9035
ATAI Life Sciences N.V. (Subject) CIK: 0001840904 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-40493 | Film No.: 25765033
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ATAI LIFE SCIENCES N.V. 180 VARICK STREET NEW YORK NY 10014
Business Address
Brand Florian (Reporting) CIK: 0001860682 (see all company filings)

Type: 144